sparkly wrote:VituVingiSana wrote:Sam_Kibs wrote:issued shares after bonus issue of 1:1 should be half of the 25 i.e around or back to where it was
Good point and they should have adjusted for it by showing the 'diluted' EPS. Nevertheless, the PAT & effective EPS has doubled even after ignoring biological gains. Good show!
Finance income most likely a result of the weak shilling. Revaluation of biological assets (tea bushes) is arbitrary.
Good show on the improved profit from operations though still low considering that the turnover is 0.5B. I find the tea companies rather stingy on operating costs information.
Tea is FMCG. It's hard to get higher margins in the commodity business. Tea sold as a commodity has low margins. If anything, these are good margins. The ultimate parent [Williamson UK] does get plenty of cream at the top with the branded business.
A lesson for KETEPA & KTDA... tap the retail market like Tata-Tetley have done.
What I like about Williamson and Kapchorua is they have locked in sales of their produce i.e. they don't speculate. They produce what they have already sold. It doesn't always work out to their benefit but overall it's good management.
Kakuzi does a good job by publishing a mini-annual report with lots of data vs the rest.
Greedy when others are fearful. Very fearful when others are greedy - to paraphrase Warren Buffett